Policy | July 27, 2022
Bulk Drug Park in the country :PIB
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
The tenure of contract will be upto 10 years from date of signing the contract/installation.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Merck’s first microbiology application and training lab in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
